Forbion Growth Sponsor FEAC I B.V.
SEC CIK 1897943 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ENGN | enGene Therapeutics Inc. | 10% | 1.50M | — | — | 1 | 2023-10-31 | 2023-10-31 |
Most active insiders at ENGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Grossman William | Interim Chief Medical Off, Dir | $10.1K | — |
Forbion Growth Sponsor FEAC I B.V. made no open-market trades at ENGN in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2023-11-02 | 2023-10-31 | ENGN | enGene Therapeutics Inc. | Forbion Growth Sponsor FEAC I B.V. | 10% | J - Other | — | +2.39M | 1.50M | New | — |
Purchase Sale Sale after option exercise All abbreviations